Klebsiella pneumoniae: an update on antibiotic resistance mechanisms
- PMID: 36632990
- DOI: 10.2217/fmb-2022-0097
Klebsiella pneumoniae: an update on antibiotic resistance mechanisms
Abstract
Klebsiella pneumoniae colonizes mucosal surfaces of healthy humans and is responsible for one third of all Gram-negative infections in hospitalized patients. K. pneumoniae is compatible with acquiring antibiotic resistance elements such as plasmids and transposons encoding various β-lactamases and efflux pumps. Mutations in different proteins such as β-lactamases, efflux proteins, outer membrane proteins, gene replication enzymes, protein synthesis complexes and transcription enzymes also generate resistance to antibiotics. Biofilm formation is another strategy that facilitates antibiotic resistance. Resistant strains can be treated by combination therapy using available antibiotics, though proper management of antibiotic consumption in hospitals is important to reduce the emergence and proliferation of resistance to current antibiotics.
Keywords: Klebsiella pneumoniae; antibiotics; drug resistance; infection; mechanisms.
Similar articles
-
Alliance of Efflux Pumps with β-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates.Microb Drug Resist. 2019 Oct;25(8):1155-1163. doi: 10.1089/mdr.2018.0414. Microb Drug Resist. 2019. PMID: 31613200 Free PMC article.
-
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.Antimicrob Agents Chemother. 2017 Feb 23;61(3):e02097-16. doi: 10.1128/AAC.02097-16. Print 2017 Mar. Antimicrob Agents Chemother. 2017. PMID: 28031201 Free PMC article.
-
Co-Occurrence of Rare ArmA-, RmtB-, and KPC-2-Encoding Multidrug-Resistant Plasmids and Hypervirulence iuc Operon in ST11-KL47 Klebsiella pneumoniae.Microbiol Spectr. 2022 Apr 27;10(2):e0237121. doi: 10.1128/spectrum.02371-21. Epub 2022 Mar 24. Microbiol Spectr. 2022. PMID: 35323034 Free PMC article.
-
Relationship between biofilm formation and antibiotic resistance of Klebsiella pneumoniae and updates on antibiofilm therapeutic strategies.Front Cell Infect Microbiol. 2024 Feb 23;14:1324895. doi: 10.3389/fcimb.2024.1324895. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38465230 Free PMC article. Review.
-
Plasmids carrying DHA-1 β-lactamases.Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1197-1209. doi: 10.1007/s10096-018-3231-9. Epub 2018 Apr 17. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29663096 Review.
Cited by
-
Antibacterial Activity of Jelleine-I, a Peptide Isolated from Royal Jelly of Apis mellifera, Against Colistin-Resistant Klebsiella pneumoniae.Toxins (Basel). 2025 Jun 25;17(7):325. doi: 10.3390/toxins17070325. Toxins (Basel). 2025. PMID: 40711136 Free PMC article.
-
A review of the mechanisms that confer antibiotic resistance in pathotypes of E. coli.Front Cell Infect Microbiol. 2024 Apr 4;14:1387497. doi: 10.3389/fcimb.2024.1387497. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38638826 Free PMC article. Review.
-
Genome analyses of colistin-resistant high-risk blaNDM-5 producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings.BMC Microbiol. 2024 May 20;24(1):174. doi: 10.1186/s12866-024-03306-4. BMC Microbiol. 2024. PMID: 38769479 Free PMC article.
-
Prevalence and antimicrobial susceptibility pattern of Klebsiella pneumoniae isolated from various clinical specimens at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.BMC Infect Dis. 2024 Sep 4;24(1):917. doi: 10.1186/s12879-024-09811-1. BMC Infect Dis. 2024. PMID: 39232652 Free PMC article.
-
Linoleic acid acts as a potential anti-virulence agent in Klebsiella pneumoniae.Germs. 2024 Jun 30;14(2):136-148. doi: 10.18683/germs.2024.1426. eCollection 2024 Jun. Germs. 2024. PMID: 39493740 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources